First gene therapy and plant-based expression vector products approved in 2012.
Apr 1, 2013
By:
Gary Walsh, PhD
First gene therapy and plant-based expression vector products approved in 2012.
|
A review of new biologic drug approvals over the years, featuring highlights from 2010 and 2011.
Jun 1, 2012
By:
Gary Walsh, PhD
A review of new biologic drug approvals over the years, featuring highlights from 2010 and 2011.
|
Biotech approvals were up last year. Is it a sign of a new trend?
Oct 1, 2010
By:
Gary Walsh, PhD
Biotech approvals were up last year. Is it a sign of a new trend?
|
Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.
Oct 1, 2009
By:
Gary Walsh, PhD
Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.
|
More than 70% of the products were produced in mammalian cells.
Oct 1, 2008
By:
Gary Walsh, PhD
The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.
|
Apr 1, 2008
By:
Gary Walsh, PhD
The book is a useful, comprehensive, and truly an excellent reference source of biopharmaceutical information.
|
|
An overall increasing proportion of future product approvals will be engineered in some way, either directly or indirectly.
Nov 1, 2007
By:
Gary Walsh, PhD
An overall increasing proportion of future product approvals will be engineered in some way, either directly or indirectly.
|
|
Thirteen biopharmaceuticals gained marketing authorization
Sep 1, 2007
By:
Gary Walsh, PhD
There were notable approvals in nonparenteral delivery systems and biosimiliars in 2006.
|
Aug 1, 2006
By:
Gary Walsh, PhD
In 2005, 10 biopharma- ceuticals gained marketing approval in the US or Europe, although only five of them were genuinely new molecular entities.
|
|
